Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

Abstract

Quiz Ref ID Only approximately 30% of individuals with type 1 diabetes meet the American Diabetes Association goal of hemoglobin A_1c (HbA_1c) level of 7.5% (58 mmol/mol) for children (1 indicating the need for better approaches to diabetes management. Continuous glucose monitoring (CGM) with glucose measurements as often as every 5 minutes, plus low and high glucose level alerts and glucose trend information, has the capability of better informing diabetes management decisions than blood glucose meter testing performed several times a day. Randomized clinical trials have demonstrated the benefit of CGM in adults with type 1 diabetes, but not consistently in children, to improve glycemic control as measured by HbA_1c level and to reduce hypoglycemia.^2-6 These previous trials have either completely or predominantly included insulin pump users,^2,4,5 although the majority of adults with type 1 diabetes deliver insulin via injections.^7,8